Rajneesh Patil

Title: Innovations of Rajneesh Patil in Machine Learning for Clinical Trials

Introduction

Rajneesh Patil is an accomplished inventor based in Durham, NC (US). He has made significant contributions to the field of machine learning, particularly in the evaluation of clinical trial data. With a total of 2 patents, his work is paving the way for advancements in clinical research methodologies.

Latest Patents

One of Rajneesh Patil's latest patents is titled "Machine Learning Techniques for Automatic Evaluation of Clinical Trial Data." This patent describes systems and methods that utilize machine-learning techniques to evaluate clinical trial data. The invention focuses on identifying anomalies that represent adverse events associated with clinical trial investigations. By employing one or more learning models trained on historical investigation data, the system can assess compliance risks effectively. The process involves obtaining investigation data from clinical trial sites and selecting models tailored to those sites. A score is then determined based on the investigation data, indicating the likelihood of compliance risks.

Career Highlights

Rajneesh Patil is currently employed at IQVIA Inc., a leading company in the field of healthcare data analytics. His role involves leveraging his expertise in machine learning to enhance clinical trial processes. His innovative approaches are contributing to more efficient and reliable evaluations in clinical research.

Collaborations

Rajneesh has collaborated with notable colleagues such as Nithyanandan Thangavelu and Jian Huang. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in their respective fields.

Conclusion

Rajneesh Patil's work in machine learning for clinical trials exemplifies the intersection of technology and healthcare. His patents and contributions are instrumental in improving the evaluation processes in clinical research, ultimately benefiting patient safety and treatment efficacy.